Inhibition of antiapoptotic BCL-2 proteins with ABT-263 induces fibroblast apoptosis, reversing persistent pulmonary fibrosisJoseph Cooley(National Jewish Health), Elizabeth F. Redente(National Jewish Health)JCI InsightFebruary 7, 202310.1172/jci.insight.163762Cited by 67SaveCiteExport RISWatch citationsRelated PapersLoss of Fas signaling in fibroblasts impairs homeostatic fibrosis resolution and promotes persistent pulmonary fibrosis|JCI Insight|2020|61Conditional BCL-2 Expression in Fibroblasts Promotes Persistent Pulmonary Fibrosis which is Reversible by Therapeutic BCL-2 Inhibition|Nature Communications|2026|0